{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:14:23Z","timestamp":1791645263259,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016802","name":"Natural Science Foundation of Changzhou Municipality","doi-asserted-by":"publisher","award":["CJ20243023"],"award-info":[{"award-number":["CJ20243023"]}],"id":[{"id":"10.13039\/100016802","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changzhou Third Peopls's Hospital","award":["Key Talents Project"],"award-info":[{"award-number":["Key Talents Project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02649-7","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:18:29Z","timestamp":1751955509000},"page":"2445-2457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of serum chitinase-3-like protein 1 with sarcopenia in patients with type 2 diabetes mellitus"],"prefix":"10.1007","volume":"48","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-8842","authenticated-orcid":false,"given":"Wenjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2649_CR1","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia Lancet 393:2636\u20132646. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9","DOI":"10.1016\/s0140-6736(19)31138-9"},{"key":"2649_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, Celis-Morales C (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13:86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2649_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s41999-022-00627-3","volume":"13","author":"N Veronese","year":"2022","unstructured":"Veronese N, Koyanagi A, Cereda E, Maggi S, Barbagallo M, Dominguez LJ, Smith L (2022) Sarcopenia reduces quality of life in the long-term: longitudinal analyses from the english longitudinal study of ageing. Eur Geriatr Med 13:633\u2013639. https:\/\/doi.org\/10.1007\/s41999-022-00627-3","journal-title":"Eur Geriatr Med"},{"key":"2649_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SSY Yeung","year":"2019","unstructured":"Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, Maier AB (2019) Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 10:485\u2013500. https:\/\/doi.org\/10.1002\/jcsm.12411","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2649_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12877-019-1195-y","volume":"19","author":"X Zhang","year":"2019","unstructured":"Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, Deng R, Cheng ASK (2019) Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr 19:183. https:\/\/doi.org\/10.1186\/s12877-019-1195-y","journal-title":"BMC Geriatr"},{"key":"2649_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12877-018-0878-0","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang W, Wang C, Tao W, Dou Q, Yang Y (2018) Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis. BMC Geriatr 18:188. https:\/\/doi.org\/10.1186\/s12877-018-0878-0","journal-title":"BMC Geriatr"},{"key":"2649_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.maturitas.2018.11.003","volume":"119","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re O, Beaudart C, Ethgen O, Reginster JY, Locquet M (2019) The health economics burden of sarcopenia: a systematic review. Maturitas 119:61\u201369. https:\/\/doi.org\/10.1016\/j.maturitas.2018.11.003","journal-title":"Maturitas"},{"key":"2649_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jcsm.12224","volume":"8","author":"AM Martone","year":"2017","unstructured":"Martone AM, Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A, Corica F, Di Bari M, Maggio M, Manca GM, Marzetti E, Rizzo MR, Rossi A, Volpato S, Landi F (2017) The incidence of sarcopenia among hospitalized older patients: results from the glisten study. J Cachexia Sarcopenia Muscle 8:907\u2013914. https:\/\/doi.org\/10.1002\/jcsm.12224","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2649_CR9","doi-asserted-by":"publisher","first-page":"38937","DOI":"10.1038\/srep38937","volume":"6","author":"T Wang","year":"2016","unstructured":"Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q, Hu X, Tao R, Li L, Qian F, Yu L (2016) Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep 6:38937. https:\/\/doi.org\/10.1038\/srep38937","journal-title":"Sci Rep"},{"key":"2649_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13098-018-0326-5","volume":"10","author":"H Trierweiler","year":"2018","unstructured":"Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, Zeghbi Cochenski Borba V (2018) Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr 10:25. https:\/\/doi.org\/10.1186\/s13098-018-0326-5","journal-title":"Diabetol Metab Syndr"},{"key":"2649_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","volume":"107","author":"P Anagnostis","year":"2020","unstructured":"Anagnostis P, Gkekas NK, Achilla C, Pananastasiou G, Taouxidou P, Mitsiou M, Kenanidis E, Potoupnis M, Tsiridis E, Goulis DG (2020) Type 2 diabetes mellitus is associated with increased risk of sarcopenia: A systematic review and Meta-analysis. Calcif Tissue Int 107:453\u2013463. https:\/\/doi.org\/10.1007\/s00223-020-00742-y","journal-title":"Calcif Tissue Int"},{"key":"2649_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010183","author":"A Izzo","year":"2021","unstructured":"Izzo A, Massimino E, Riccardi G, Della Pepa G (2021) A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. Nutrients 13:183. https:\/\/doi.org\/10.3390\/nu13010183","journal-title":"Nutrients"},{"key":"2649_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1900\/rds.2022.18.157","volume":"18","author":"D Purnamasari","year":"2022","unstructured":"Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW (2022) Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev Diabet Stud 18:157\u2013165. https:\/\/doi.org\/10.1900\/rds.2022.18.157","journal-title":"Rev Diabet Stud"},{"key":"2649_CR14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/dmso.S410834","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X (2023) The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy. Diabetes Metab Syndr Obes 16:1541\u20131554. https:\/\/doi.org\/10.2147\/dmso.S410834","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2649_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu16010063","author":"G Lisco","year":"2023","unstructured":"Lisco G, Disoteo OE, De Tullio A, De Geronimo V, Giagulli VA, Monzani F, Jirillo E, Cozzi R, Guastamacchia E, De Pergola G, Triggiani V (2023) Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age. Nutrients 16:63. https:\/\/doi.org\/10.3390\/nu16010063","journal-title":"Nutrients"},{"key":"2649_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00592-022-01883-2","volume":"59","author":"HA Giha","year":"2022","unstructured":"Giha HA, Alamin OAO, Sater MS (2022) Diabetic sarcopenia: metabolic and molecular appraisal. Acta Diabetol 59:989\u20131000. https:\/\/doi.org\/10.1007\/s00592-022-01883-2","journal-title":"Acta Diabetol"},{"key":"2649_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","volume":"96","author":"G Bano","year":"2017","unstructured":"Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, Manzato E, Sergi G, Veronese N (2017) Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas 96:10\u201315. https:\/\/doi.org\/10.1016\/j.maturitas.2016.11.006","journal-title":"Maturitas"},{"key":"2649_CR18","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/dmso.S186600","volume":"12","author":"J Mesinovic","year":"2019","unstructured":"Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D (2019) Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes 12:1057\u20131072. https:\/\/doi.org\/10.2147\/dmso.S186600","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2649_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao T, Su Z, Li Y, Zhang X, You Q (2020) Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther 5:201. https:\/\/doi.org\/10.1038\/s41392-020-00303-7","journal-title":"Signal Transduct Target Ther"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"110680","DOI":"10.1016\/j.biopha.2020.110680","volume":"131","author":"S Wang","year":"2020","unstructured":"Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y (2020) CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 131:110680. https:\/\/doi.org\/10.1016\/j.biopha.2020.110680","journal-title":"Biomed Pharmacother"},{"key":"2649_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"Yu JE, Yeo IJ, Han SB, Yun J, Kim B, Yong YJ, Lim YS, Kim TH, Son DJ, Hong JT (2024) Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med 56:1\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01131-9","journal-title":"Exp Mol Med"},{"key":"2649_CR22","doi-asserted-by":"publisher","first-page":"109856","DOI":"10.1016\/j.clim.2023.109856","volume":"257","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu Z, Liu Y (2023) The potential roles and mechanisms of Chitinase-3-like-1 in the pathogenesis of type 2-biased airway diseases. Clin Immunol 257:109856. https:\/\/doi.org\/10.1016\/j.clim.2023.109856","journal-title":"Clin Immunol"},{"key":"2649_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00011-005-0010-8","volume":"55","author":"CN Rathcke","year":"2006","unstructured":"Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 55:53\u201359. https:\/\/doi.org\/10.1007\/s00011-005-0010-8","journal-title":"Inflamm Res"},{"key":"2649_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.metabol.2011.09.004","volume":"61","author":"I Kyrgios","year":"2012","unstructured":"Kyrgios I, Galli-Tsinopoulou A, Stylianou C, Papakonstantinou E, Arvanitidou M, Haidich AB (2012) Elevated Circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 61:562\u2013568. https:\/\/doi.org\/10.1016\/j.metabol.2011.09.004","journal-title":"Metabolism"},{"key":"2649_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/1354750x.2014.992475","volume":"20","author":"E \u017burawska-P\u0142aksej","year":"2015","unstructured":"\u017burawska-P\u0142aksej E, \u0141ugowska A, Hetma\u0144czyk K, Knapik-Kordecka M, Adamiec R, Piwowar A (2015) Proteins from the 18 Glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2. Biomarkers 20:52\u201357. https:\/\/doi.org\/10.3109\/1354750x.2014.992475","journal-title":"Biomarkers"},{"key":"2649_CR26","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.dsx.2021.102366","volume":"16","author":"IR Sianipar","year":"2022","unstructured":"Sianipar IR, Sestramita S, Pradnjaparamita T, Yunir E, Harbuwono DS, Soewondo P, Tahapary DL (2022) The role of Intestinal-Fatty acid binding proteins and Chitinase-3-Like protein 1 across the spectrum of dysglycemia. Diabetes Metab Syndr 16:102366. https:\/\/doi.org\/10.1016\/j.dsx.2021.102366","journal-title":"Diabetes Metab Syndr"},{"key":"2649_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000444855","volume":"83","author":"M Di Rosa","year":"2016","unstructured":"Di Rosa M, Malaguarnera L (2016) Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications. Pathobiology 83:228\u2013242. https:\/\/doi.org\/10.1159\/000444855","journal-title":"Pathobiology"},{"key":"2649_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12020-010-9334-4","volume":"37","author":"A Sonmez","year":"2010","unstructured":"Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M (2010) Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine 37:455\u2013459. https:\/\/doi.org\/10.1007\/s12020-010-9334-4","journal-title":"Endocrine"},{"key":"2649_CR29","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cellsig.2013.03.016","volume":"25","author":"M Prakash","year":"2013","unstructured":"Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, Eriksson C (2013) Diverse pathological implications of YKL-40: answers May lie in \u2018outside-in\u2019 signaling. Cell Signal 25:1567\u20131573. https:\/\/doi.org\/10.1016\/j.cellsig.2013.03.016","journal-title":"Cell Signal"},{"key":"2649_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.metabol.2019.03.010","volume":"95","author":"DH Lee","year":"2019","unstructured":"Lee DH, Han JH, Lee YS, Jung YS, Roh YS, Yun JS, Han SB, Hong JT (2019) Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by Inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis. Metabolism 95:46\u201356. https:\/\/doi.org\/10.1016\/j.metabol.2019.03.010","journal-title":"Metabolism"},{"key":"2649_CR31","doi-asserted-by":"publisher","unstructured":"Diagnosis and classification of diabetes mellitus (2014) Diabetes Care 37(Suppl 1):S81\u201390. https:\/\/doi.org\/10.2337\/dc14-S081","DOI":"10.2337\/dc14-S081"},{"key":"2649_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300\u2013307e302. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"2649_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"2649_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.maturitas.2020.04.017","volume":"138","author":"F Petermann-Rocha","year":"2020","unstructured":"Petermann-Rocha F, Ho FK, Welsh P, Mackay D, Brown R, Gill JMR, Sattar N, Gray SR, Pell JP, Celis-Morales CA (2020) Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: A prospective study from UK biobank. Maturitas 138:69\u201375. https:\/\/doi.org\/10.1016\/j.maturitas.2020.04.017","journal-title":"Maturitas"},{"key":"2649_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091864","author":"S Sbrignadello","year":"2022","unstructured":"Sbrignadello S, G\u00f6bl C, Tura A (2022) Bioelectrical Impedance Analysis for the Assessment of Body Composition in Sarcopenia and Type 2 Diabetes. Nutrients 14:1864. https:\/\/doi.org\/10.3390\/nu14091864","journal-title":"Nutrients"},{"key":"2649_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/dmso.S237362","volume":"13","author":"Q Yang","year":"2020","unstructured":"Yang Q, Zhang Y, Zeng Q, Yang C, Shi J, Zhang C, Ni X, Du Z, Tang Z, Hu J, Li X, Cai J, Li Q, Cheng Q (2020) Correlation between diabetic peripheral neuropathy and sarcopenia in patients with type 2 diabetes mellitus and diabetic foot disease: A Cross-Sectional study. Diabetes Metab Syndr Obes 13:377\u2013386. https:\/\/doi.org\/10.2147\/dmso.S237362","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2649_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s13340-017-0339-6","volume":"9","author":"Y Murata","year":"2018","unstructured":"Murata Y, Kadoya Y, Yamada S, Sanke T (2018) Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. Diabetol Int 9:136\u2013142. https:\/\/doi.org\/10.1007\/s13340-017-0339-6","journal-title":"Diabetol Int"},{"key":"2649_CR38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jamda.2016.07.007","volume":"17","author":"A Liccini","year":"2016","unstructured":"Liccini A, Malmstrom TK (2016) Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 17:846\u2013851. https:\/\/doi.org\/10.1016\/j.jamda.2016.07.007","journal-title":"J Am Med Dir Assoc"},{"key":"2649_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12877-019-1137-8","volume":"19","author":"FY Fung","year":"2019","unstructured":"Fung FY, Koh YLE, Malhotra R, Ostbye T, Lee PY, Shariff Ghazali S, Tan NC (2019) Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatr 19:122. https:\/\/doi.org\/10.1186\/s12877-019-1137-8","journal-title":"BMC Geriatr"},{"key":"2649_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/gerona\/glv108","volume":"71","author":"P Han","year":"2016","unstructured":"Han P, Kang L, Guo Q, Wang J, Zhang W, Shen S, Wang X, Dong R, Ma Y, Shi Y, Shi Z, Li H, Li C, Ma Y, Wang L, Niu K (2016) Prevalence and factors associated with sarcopenia in Suburb-dwelling older Chinese using the Asian working group for sarcopenia definition. J Gerontol Biol Sci Med Sci 71:529\u2013535. https:\/\/doi.org\/10.1093\/gerona\/glv108","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"2649_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00774-013-0468-3","volume":"32","author":"Q Cheng","year":"2014","unstructured":"Cheng Q, Zhu X, Zhang X, Li H, Du Y, Hong W, Xue S, Zhu H (2014) A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass. J Bone Min Metab 32:78\u201388. https:\/\/doi.org\/10.1007\/s00774-013-0468-3","journal-title":"J Bone Min Metab"},{"key":"2649_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00223-017-0277-0","volume":"101","author":"SC Shaw","year":"2017","unstructured":"Shaw SC, Dennison EM, Cooper C (2017) Epidemiology of sarcopenia: determinants throughout the lifecourse. Calcif Tissue Int 101:229\u2013247. https:\/\/doi.org\/10.1007\/s00223-017-0277-0","journal-title":"Calcif Tissue Int"},{"key":"2649_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc14-1166","volume":"38","author":"RR Kalyani","year":"2015","unstructured":"Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L (2015) Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care 38:82\u201390. https:\/\/doi.org\/10.2337\/dc14-1166","journal-title":"Diabetes Care"},{"key":"2649_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ggi.12688","volume":"16","author":"H Umegaki","year":"2016","unstructured":"Umegaki H (2016) Sarcopenia and frailty in older patients with diabetes mellitus. Geriatr Gerontol Int 16:293\u2013299. https:\/\/doi.org\/10.1111\/ggi.12688","journal-title":"Geriatr Gerontol Int"},{"key":"2649_CR45","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1096\/fj.01-0183com","volume":"15","author":"B Ramamurthy","year":"2001","unstructured":"Ramamurthy B, H\u00f6\u00f6k P, Jones AD, Larsson L (2001) Changes in myosin structure and function in response to glycation. Faseb J 15:2415\u20132422. https:\/\/doi.org\/10.1096\/fj.01-0183com","journal-title":"Faseb J"},{"key":"2649_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2840-8-61","volume":"8","author":"CN Rathcke","year":"2009","unstructured":"Rathcke CN, Vestergaard H (2009) YKL-40\u2013an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 8:61. https:\/\/doi.org\/10.1186\/1475-2840-8-61","journal-title":"Cardiovasc Diabetol"},{"key":"2649_CR47","doi-asserted-by":"publisher","first-page":"e0141730","DOI":"10.1371\/journal.pone.0141730","volume":"10","author":"E \u017burawska-P\u0142aksej","year":"2015","unstructured":"\u017burawska-P\u0142aksej E, \u0141ugowska A, Hetma\u0144czyk K, Knapik-Kordecka M, Piwowar A (2015) Neutrophils as a source of chitinases and Chitinase-Like proteins in type 2 diabetes. PLoS ONE 10:e0141730. https:\/\/doi.org\/10.1371\/journal.pone.0141730","journal-title":"PLoS ONE"},{"key":"2649_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020201","author":"S Zhang","year":"2021","unstructured":"Zhang S, Sousa A, Lin M, Iwano A, Jain R, Ma B, Lee CM, Park JW, Kamle S, Carlson R, Lee GG, Elias JA, Wands JR (2021) Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease. Cells 10:201. https:\/\/doi.org\/10.3390\/cells10020201","journal-title":"Cells"},{"key":"2649_CR49","doi-asserted-by":"publisher","first-page":"102538","DOI":"10.1016\/j.redox.2022.102538","volume":"58","author":"D Lu","year":"2022","unstructured":"Lu D, Lin Z, Wang R, Chen Z, Zhuo J, Xu L, Pan L, Li H, Yang X, He C, Shen W, Yang M, Li H, Chen H, Tan W, Wei X, Zheng S, Xu X (2022) Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer. Redox Biol 58:102538. https:\/\/doi.org\/10.1016\/j.redox.2022.102538","journal-title":"Redox Biol"},{"key":"2649_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.atherosclerosis.2012.03.034","volume":"222","author":"K Batinic","year":"2012","unstructured":"Batinic K, H\u00f6baus C, Grujicic M, Steffan A, Jelic F, Lorant D, H\u00f6rtenhuber T, Hoellerl F, Brix JM, Schernthaner G, Koppensteiner R, Schernthaner GH (2012) YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. Atherosclerosis 222:557\u2013563. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.03.034","journal-title":"Atherosclerosis"},{"key":"2649_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diabres.2011.12.008","volume":"96","author":"F Persson","year":"2012","unstructured":"Persson F, Rathcke CN, Gall MA, Parving HH, Vestergaard H, Rossing P (2012) High YKL-40 levels predict mortality in patients with type 2 diabetes. Diabetes Res Clin Pract 96:84\u201389. https:\/\/doi.org\/10.1016\/j.diabres.2011.12.008","journal-title":"Diabetes Res Clin Pract"},{"key":"2649_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12603-018-1137-y","volume":"23","author":"AHE K\u00fc\u00e7\u00fckdiler","year":"2019","unstructured":"K\u00fc\u00e7\u00fckdiler AHE, Varl\u0131 M, Yavuz \u00d6, Yal\u00e7\u0131n A, Selvi \u00d6ztorun H, Devrim E, Aras S (2019) Evaluation of oxidative stress parameters and antioxidant status in plasma and erythrocytes of elderly diabetic patients with sarcopenia. J Nutr Health Aging 23:239\u2013245. https:\/\/doi.org\/10.1007\/s12603-018-1137-y","journal-title":"J Nutr Health Aging"},{"key":"2649_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1298\/ptr.R0002","volume":"21","author":"T Nomura","year":"2018","unstructured":"Nomura T, Kawae T, Kataoka H, Ikeda Y (2018) Aging, physical activity, and diabetic complications related to loss of muscle strength in patients with type 2 diabetes. Phys Ther Res 21:33\u201338. https:\/\/doi.org\/10.1298\/ptr.R0002","journal-title":"Phys Ther Res"},{"key":"2649_CR54","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.arr.2020.101185","volume":"64","author":"CSL Tuttle","year":"2020","unstructured":"Tuttle CSL, Thang LAN, Maier AB (2020) Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis. Ageing Res Rev 64:101185. https:\/\/doi.org\/10.1016\/j.arr.2020.101185","journal-title":"Ageing Res Rev"},{"key":"2649_CR55","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","volume":"289","author":"K Esposito","year":"2003","unstructured":"Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799\u20131804. https:\/\/doi.org\/10.1001\/jama.289.14.1799","journal-title":"JAMA"},{"key":"2649_CR56","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.2337\/db08-0182","volume":"57","author":"AR Nielsen","year":"2008","unstructured":"Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P, Krogh-Madsen R, Taudorf S, Lindegaard B, Pedersen BK (2008) Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 57:3078\u20133082. https:\/\/doi.org\/10.2337\/db08-0182","journal-title":"Diabetes"},{"key":"2649_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00535-017-1370-x","volume":"53","author":"Y Kitajima","year":"2018","unstructured":"Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y (2018) Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol 53:427\u2013437. https:\/\/doi.org\/10.1007\/s00535-017-1370-x","journal-title":"J Gastroenterol"},{"key":"2649_CR58","doi-asserted-by":"publisher","first-page":"941093","DOI":"10.3389\/fnut.2022.941093","volume":"9","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chen J, Song C, Sun J, Liu W (2022) Association between serum Iron status and muscle mass in adults: results from NHANES 2015\u20132018. Front Nutr 9:941093. https:\/\/doi.org\/10.3389\/fnut.2022.941093","journal-title":"Front Nutr"},{"key":"2649_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/nu15214536","author":"A Moroni","year":"2023","unstructured":"Moroni A, Perna S, Azzolino D, Gasparri C, Zupo R, Micheletti Cremasco M, Rondanelli M (2023) Discovering the Individualized Factors Associated with Sarcopenia and Sarcopenic Obesity Phenotypes-A Machine Learning Approach. Nutrients 15:4536. https:\/\/doi.org\/10.3390\/nu15214536","journal-title":"Nutrients"},{"key":"2649_CR60","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1038\/s41598-024-60059-w","volume":"14","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang Z, Wang Y, Ma A, Li L, Zhao G (2024) Iron status and sarcopenia-related traits: a bi-directional Mendelian randomization study. Sci Rep 14:9179. https:\/\/doi.org\/10.1038\/s41598-024-60059-w","journal-title":"Sci Rep"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:41:10Z","timestamp":1760362870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02649-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was conducted by the Declaration of Helsinki and approved by the Ethics Committee of Changzhou Third People\u2019s Hospital (decision No. 2020002). Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}